Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000198 · ClinicalTrials.gov registry record · Phase 1
Piracetam for Treatment of Cocaine Addiction - 3
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00000198: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT00000198 is a Phase 1 study that has completed, run by University of Pennsylvania. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000198, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of piracetam in an outpatient treatment program.
Interventions
- DRUG Piracetam
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-10 |
| Est. Completion | 1997-10 |
| Phase | Phase 1 |
What the finished NCT00000198 record still lists
NCT00000198 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Piracetam is the first listed.
NCT00000198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000198 about?
NCT00000198 is a clinical study titled "Piracetam for Treatment of Cocaine Addiction - 3". The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of pirac...
What is the current status of trial NCT00000198?
This trial is currently completed. It is a Phase 1 study. The study started on 1996-10. Estimated completion is 1997-10.
What interventions are being tested in trial NCT00000198?
The interventions under investigation include: Piracetam (DRUG).
Who is sponsoring clinical trial NCT00000198?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia